Klaviyo (KVYO) Form 144 Notifies Sale of 7,105 RSU Shares on NYSE
Rhea-AI Filing Summary
Klaviyo, Inc. (KVYO) reported a Form 144 notice indicating an intended sale of 7,105 common shares with an aggregate market value of $223,310.15, representing part of the issuer's 116,897,730 outstanding shares. The shares are scheduled for sale approximately on 08/18/2025 on the NYSE. The filer acquired the shares as restricted stock units on 08/15/2025 and lists payment as N/A. The filing also discloses two prior 10b5-1 sales by Stephen Rowland of 7,079 shares on 07/15/2025 (gross proceeds $223,446.27) and 06/16/2025 (gross proceeds $244,619.43).
Positive
- Planned sale disclosed under Rule 144, providing transparency about insider liquidity
- Shares were acquired as Restricted Stock Units (08/15/2025), clearly describing acquisition type
- Prior 10b5-1 sales disclosed (07/15/2025 and 06/16/2025) indicating use of pre-established trading arrangements
Negative
- None.
Insights
TL;DR: Routine insider notice showing planned sale of 7,105 RSU-derived shares under Rule 144; prior 10b5-1 executions noted.
The Form 144 for KVYO documents an intended sale of 7,105 common shares valued at $223,310.15 and confirms the shares were acquired as restricted stock units on 08/15/2025. The filing references past 10b5-1 sales by Stephen Rowland totaling 14,158 shares in June and July 2025 with stated gross proceeds. For investors, this is a standard disclosure of insider liquidity and not an operational or financial statement of company performance. The information is factual and limited to share counts, values, acquisition method, and sale timing.
TL;DR: Disclosure aligns with Rule 144 and 10b5-1 practices; statement includes insider representation about absence of undisclosed material information.
The notice includes the required representation that the seller is unaware of undisclosed material adverse information and cites reliance on a trading plan in prior sales (10b5-1). It documents acquisition via RSUs and lists broker details for the planned sale. This filing is procedural and reflects compliance with securities-sale reporting obligations rather than a governance change or event with direct company-level implications.